NO20004351D0 - Nye asymmetrisk substituerte karboksylsyrederivater, fremgangsmÕte for fremstilling av dem og deres anvendelse som blandete ETA/ETB-reseptorantagonister - Google Patents
Nye asymmetrisk substituerte karboksylsyrederivater, fremgangsmÕte for fremstilling av dem og deres anvendelse som blandete ETA/ETB-reseptorantagonisterInfo
- Publication number
- NO20004351D0 NO20004351D0 NO20004351A NO20004351A NO20004351D0 NO 20004351 D0 NO20004351 D0 NO 20004351D0 NO 20004351 A NO20004351 A NO 20004351A NO 20004351 A NO20004351 A NO 20004351A NO 20004351 D0 NO20004351 D0 NO 20004351D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- carboxylic acid
- acid derivatives
- receptor antagonists
- substituted carboxylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19809144A DE19809144A1 (de) | 1998-03-04 | 1998-03-04 | Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten |
| PCT/EP1999/001208 WO1999044998A1 (de) | 1998-03-04 | 1999-02-25 | Neue unsymmetrisch substituierte carbonsäurederivate, ihre herstellung und verwendung als gemischte eta/etb-rezeptorantagonisten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004351L NO20004351L (no) | 2000-09-01 |
| NO20004351D0 true NO20004351D0 (no) | 2000-09-01 |
Family
ID=7859627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004351A NO20004351D0 (no) | 1998-03-04 | 2000-09-01 | Nye asymmetrisk substituerte karboksylsyrederivater, fremgangsmÕte for fremstilling av dem og deres anvendelse som blandete ETA/ETB-reseptorantagonister |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1060167A1 (no) |
| JP (1) | JP2002505324A (no) |
| KR (1) | KR20010041537A (no) |
| CN (1) | CN1292782A (no) |
| AR (1) | AR020317A1 (no) |
| AU (1) | AU2624799A (no) |
| BG (1) | BG104754A (no) |
| BR (1) | BR9908401A (no) |
| CA (1) | CA2322541A1 (no) |
| CO (1) | CO5080805A1 (no) |
| DE (1) | DE19809144A1 (no) |
| HR (1) | HRP20000650A2 (no) |
| HU (1) | HUP0101173A3 (no) |
| ID (1) | ID26183A (no) |
| IL (1) | IL137537A0 (no) |
| NO (1) | NO20004351D0 (no) |
| PL (1) | PL342806A1 (no) |
| SK (1) | SK11752000A3 (no) |
| TR (1) | TR200002545T2 (no) |
| TW (1) | TW509676B (no) |
| WO (1) | WO1999044998A1 (no) |
| ZA (1) | ZA991738B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19924892A1 (de) * | 1999-06-01 | 2000-12-07 | Basf Ag | Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| CA2386230C (en) * | 1999-10-06 | 2009-05-05 | Basf Aktiengesellschaft | Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4411225A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| DE19636046A1 (de) * | 1996-09-05 | 1998-03-12 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten |
-
1998
- 1998-03-04 DE DE19809144A patent/DE19809144A1/de not_active Withdrawn
-
1999
- 1999-02-25 EP EP99906251A patent/EP1060167A1/de not_active Withdrawn
- 1999-02-25 PL PL99342806A patent/PL342806A1/xx unknown
- 1999-02-25 BR BR9908401-5A patent/BR9908401A/pt not_active IP Right Cessation
- 1999-02-25 ID IDW20001703A patent/ID26183A/id unknown
- 1999-02-25 HU HU0101173A patent/HUP0101173A3/hu unknown
- 1999-02-25 KR KR1020007009714A patent/KR20010041537A/ko not_active Application Discontinuation
- 1999-02-25 CN CN998036315A patent/CN1292782A/zh active Pending
- 1999-02-25 AU AU26247/99A patent/AU2624799A/en not_active Abandoned
- 1999-02-25 IL IL13753799A patent/IL137537A0/xx unknown
- 1999-02-25 CA CA002322541A patent/CA2322541A1/en not_active Abandoned
- 1999-02-25 TR TR2000/02545T patent/TR200002545T2/xx unknown
- 1999-02-25 WO PCT/EP1999/001208 patent/WO1999044998A1/de not_active Application Discontinuation
- 1999-02-25 JP JP2000534541A patent/JP2002505324A/ja active Pending
- 1999-02-25 SK SK1175-2000A patent/SK11752000A3/sk unknown
- 1999-03-04 ZA ZA9901738A patent/ZA991738B/xx unknown
- 1999-03-04 TW TW088103317A patent/TW509676B/zh active
- 1999-03-04 AR ARP990100920A patent/AR020317A1/es not_active Application Discontinuation
- 1999-03-04 CO CO99013467A patent/CO5080805A1/es unknown
-
2000
- 2000-09-01 NO NO20004351A patent/NO20004351D0/no not_active Application Discontinuation
- 2000-09-07 BG BG104754A patent/BG104754A/xx unknown
- 2000-10-03 HR HR20000650A patent/HRP20000650A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL137537A0 (en) | 2001-07-24 |
| ID26183A (id) | 2000-12-07 |
| EP1060167A1 (de) | 2000-12-20 |
| PL342806A1 (en) | 2001-07-02 |
| DE19809144A1 (de) | 1999-09-09 |
| SK11752000A3 (sk) | 2001-05-10 |
| AU2624799A (en) | 1999-09-20 |
| TW509676B (en) | 2002-11-11 |
| JP2002505324A (ja) | 2002-02-19 |
| HUP0101173A2 (hu) | 2002-03-28 |
| NO20004351L (no) | 2000-09-01 |
| HRP20000650A2 (en) | 2001-06-30 |
| HUP0101173A3 (en) | 2002-05-28 |
| KR20010041537A (ko) | 2001-05-25 |
| CA2322541A1 (en) | 1999-09-10 |
| CO5080805A1 (es) | 2001-09-25 |
| AR020317A1 (es) | 2002-05-08 |
| ZA991738B (en) | 2000-10-11 |
| BR9908401A (pt) | 2000-10-31 |
| CN1292782A (zh) | 2001-04-25 |
| WO1999044998A1 (de) | 1999-09-10 |
| BG104754A (en) | 2001-05-31 |
| TR200002545T2 (tr) | 2000-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005454D0 (no) | Nye hydroksyindoler, deres anvendelse som fosfodiesterase 4 inhibitorer og fremgangsmÕte for fremstilling derav | |
| EP1349839B8 (en) | Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists | |
| DK1175402T3 (da) | Piperidinderivater, der er nyttige som CCR5-antagonister | |
| PL335484A1 (en) | Derivatives of heteroarylhexamide, their production and application as selective inhibitors of mip-1a being assimilated by its ccr1 receptor | |
| NO962412L (no) | Pyrimidindion-, pyrimidintrion-, triazindion-, tetrahydrokinazolindionderivater som 1-adrenergiske reseptorantagonister | |
| NO20022532D0 (no) | Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser | |
| BRPI9811688B1 (pt) | benzamidas bicìclicas gastrocinéticas de derivados de piperidina 3- ou 4- substituìdos com 4-aminometil), processo para preparação das mesmas, composições farmacêuticas compreendendo as mesmas e processo para preparação das referidas composições. | |
| DK0885234T3 (da) | Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| NO991079D0 (no) | Azinyloksy-og fenoksy-diaryl-karboksylsyre-derivater, deres fremstilling og deres anvendelse som bladete ETA/ETB-endothelin-reseptor-antagonister | |
| DK0726893T3 (da) | Hidtil ukendte 4-piperidinyl-substituerede lactamer som neurokinon 2-receptor-antagonister til behandling af astma | |
| NO995745D0 (no) | Nye derivater av erytromycin, fremgangsmåte for fremstilling av disse, samt deres anvendelse som medikamenter | |
| HUP0101143A3 (en) | Pyridin-carboxylic acid derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical compositions containing them | |
| NO20004144D0 (no) | Heterocykliske forbindelser, deres fremstilling og anvendelse som takykinin reseptor antagonister | |
| NO20013709D0 (no) | Nye N-triazolylmetyl-piperazinderivater som neurokininreseptorantagonister | |
| HUP0201710A2 (en) | Biphenyl derivatives as antagonists of the neurokinine-1 receptor, process for producing them and pharmaceutical compositions containing them | |
| DK1390372T3 (da) | 1-oxa-3,9-diaza-spiro '5,5]undecan-2-on-derivater og anvendelse deraf som neurokininreceptorantagonist | |
| NO20015058L (no) | Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler | |
| NO20020578D0 (no) | Substituerte pyrrolidin-2,3,4-trion-3-oskimderivater som er nyttige som NMDA-reseptorantagonister | |
| NO20004351D0 (no) | Nye asymmetrisk substituerte karboksylsyrederivater, fremgangsmÕte for fremstilling av dem og deres anvendelse som blandete ETA/ETB-reseptorantagonister | |
| NO20001077D0 (no) | Nye karboksylsyrederivater, deres fremstilling og anvendelse som blandete ETA/ETB-endothelin-reseptorantagonister | |
| NO992976L (no) | Heterocykliske karboksylsyre-derivater, fremstilling og anvendelse derav som endothelinreseptor-antagonister | |
| DK0931088T3 (da) | Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler | |
| NO991622D0 (no) | Nye derivater av pentaerytritt, deres fremstilling og anvendelse sÕvel som mellomprodukt for syntese av det samme | |
| NO974205D0 (no) | Heterocyklisk-substituerte piperazinonderivater som tachykininreceptor-antagonister | |
| DK1265856T3 (da) | Hidtil ukendt fremgangsmåde til fremstillingen af alpha-(2,4-disulfophenyl)-N-tert-butylnitron og farmaceutisk acceptable salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |